Teladoc (TDOC) Stock Analysis: Buy The TDOC Dip?


This content was made for video and podcast format:


WATCH THE VIDEO HERE

LISTEN TO THE PODCAST HERE


Last month Teladoc (#TDOC) reported Q1 earnings and investors were not impressed. The technology health company announced Q1 GAAP EPS of -$1.31 (misses by $0.72) and revenue of $453.68M (+150.9% Y/Y).


Revenue did increase dramatically for the Y/Y, but the company gave stagnant growth numbers for Q2, which is not what bullish investors wanted to see for a growth stock. With weak guidance dragging the stock down, is now the time for investors to buy #Teladoc stock on the dip?


Create a Webull account and recieve 2 FREE stocks


Create a FREE TradingView account and start charting your technical analysis


Contact me if you have any questions or inquiries


Thanks to the Teladoc site for the photo of COO David Sides